Sparta Science, a Menlo Park, Calif.-based company that applies data and technology in pursuit of human resilience, raised $16m in Series B funding.
The round – which brought total capital raised to date to approximately $26m – was led by GSR Ventures U.S., with participation from Arsenal Growth, and existing investors.
The company intends to use the funds to expand its science and engineering teams, further research, and accelerate the deployment of the Sparta System globally, to include health systems, hospital networks, and corporations focused on improving the personal health of their employees.
Led by Dr. Phil Wagner, Founder and CEO, Sparta Science provides a musculoskeletal health assessment tool used by hundreds of clients, including collegiate and professional sports teams, personal health organizations, and government and military organizations. It leverages data and machine learning software to optimize health and performance for individuals. Using evidence-based movement assessments and data-driven exercise prescriptions, the system increases resilience, minimize injury risk and speed efficient rehabilitation to physical activity.
Sparta’s international client roster spans healthcare and rehabilitation, professional and collegiate sports, and the military, including partners such as the Cleveland Cavaliers, Washington Redskins, Pittsburgh Steelers, Colorado Rockies, Portland Timbers, Clemson, The Ohio State University, Auburn University, The University of Texas, Oklahoma University, UCLA, University of Pennsylvania, EXOS, NYU Orthopedics, Stanford Orthopedics, the Novant Health System and many more.